1PTH
The Structural Basis of Aspirin Activity Inferred from the Crystal Structure of Inactivated Prostaglandin H2 Synthase
Experimental procedure
Collection date | 1993-06 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 99.570, 209.800, 235.000 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 8.000 - 3.400 |
R-factor | 0.186 |
Rwork | 0.186 |
R-free | 0.22700 |
RMSD bond length | 0.013 |
RMSD bond angle | 23.700 * |
Data reduction software | MADNES |
Phasing software | X-PLOR (3.1) |
Refinement software | X-PLOR (3.1) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 15.000 |
High resolution limit [Å] | 3.400 |
Rmerge | 0.095 |
Total number of observations | 68275 * |
Number of reflections | 27154 |
Completeness [%] | 82.0 |
Redundancy | 2.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Vapor diffusion, hanging drop * | 6.7 * |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | drop | enzyme | 10 (mg/ml) | |
2 | 1 | drop | sodium phosphate | 20 (mM) | |
3 | 1 | drop | 100-200 (mM) | ||
4 | 1 | drop | beta-octyl glucopyranoside | 0.6 (%(w/v)) | |
5 | 1 | drop | PEG4000 | 2-4 (%) | |
6 | 1 | reservoir | 2-4times concentrated buffer | ||
7 | 1 | reservoir | PEG4000 | 4-8 (%) |